Opill, the first oral contraceptive approved by the FDA for over-the-counter use, has begun shipping to U.S. stores without age restrictions or a physician's sign-off, reflecting a significant development in reproductive health amid restricted access to abortion care.
More women are voicing concerns about the effects of hormonal birth control on their physical and mental well-being, challenging the pharmaceutical industry's dominance in contraception and the belief that it is the best option for preventing pregnancy.
Critiques of hormonal contraceptives, particularly the pill, highlight common side effects like mood changes, headaches, irregular bleeding, and lower libido, with some cases leading to more severe complications such as blood clots, underscoring the disregard of women's concerns by the medical establishment.
Women expressing skepticism about hormonal birth control are often labeled as antifeminist or accused of putting other women at risk, demonstrating a dismissive response to valid concerns and a lack of curiosity about improving the current birth-control landscape.
[
add
]
[
|
|
...
]